Introduction: FOXO4-DRI peptide enables selective apoptosis of senescent cells, supports metabolic research, and makes sure stability in study, boosting reproducibility and advancing growing old and oncology investigations. everyday laboratory workflows typically reveal gaps wherever current compounds are unsuccessful to address mobile senescence